These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 16024754

  • 21. Estrogen effects on neuroendocrine function: the new challenge of pulsed therapy.
    Genazzani AR, Bernardi F.
    Climacteric; 2002 Jun; 5 Suppl 2():50-6. PubMed ID: 12482112
    [Abstract] [Full Text] [Related]

  • 22. Progestins initiate adverse events of menopausal estrogen therapy.
    Thomas T, Rhodin J, Clark L, Garces A.
    Climacteric; 2003 Dec; 6(4):293-301. PubMed ID: 15011717
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article.
    Lakoski SG, Herrington DM.
    Climacteric; 2005 Dec; 8(4):317-26. PubMed ID: 16390766
    [Abstract] [Full Text] [Related]

  • 26. Estradiol associated with lower thrombotic risk than conjugated equine estrogens when used as oral HRT.
    Brown S.
    Menopause Int; 2013 Dec; 19(4):145. PubMed ID: 24479171
    [No Abstract] [Full Text] [Related]

  • 27. The case for progesterone.
    Stein DG.
    Ann N Y Acad Sci; 2005 Jun; 1052():152-69. PubMed ID: 16024758
    [Abstract] [Full Text] [Related]

  • 28. ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease.
    American College of Obstetricians and Gynecologists Committee on Gynecologic Practice.
    Obstet Gynecol; 2008 Nov; 112(5):1189-92. PubMed ID: 18978127
    [Abstract] [Full Text] [Related]

  • 29. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
    Kang BM, Kim MR, Park HM, Yoon BK, Lee BS, Chung HW, Cho SH, Choi H, Kim JG.
    Menopause; 2006 Nov; 13(1):125-9. PubMed ID: 16607108
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. New hormonal therapies and regimens in the postmenopause: routes of administration and timing of initiation.
    Sitruk-Ware R.
    Climacteric; 2007 Oct; 10(5):358-70. PubMed ID: 17852138
    [Abstract] [Full Text] [Related]

  • 32. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration.
    Stefanick ML.
    Am J Med; 2005 Dec 19; 118 Suppl 12B():64-73. PubMed ID: 16414329
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
    Shulman LP.
    J Fam Pract; 2004 Jul 19; Suppl():S13-7. PubMed ID: 15251108
    [No Abstract] [Full Text] [Related]

  • 36. Drug delivery systems for hormone therapy.
    Yoo JW, Lee CH.
    J Control Release; 2006 May 01; 112(1):1-14. PubMed ID: 16530874
    [Abstract] [Full Text] [Related]

  • 37. Adequate reduction degree of pituitary gonadotropin levels in the clinical management of short-term hormone replacement therapy of women with menopausal symptoms.
    Ushiroyama T, Sakuma K, Ikeda A, Ueki M.
    J Med; 2004 May 01; 35(1-6):281-94. PubMed ID: 18084886
    [Abstract] [Full Text] [Related]

  • 38. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H, Stevenson J.
    Gynecol Endocrinol; 2006 Jun 01; 22(6):303-17. PubMed ID: 16785155
    [Abstract] [Full Text] [Related]

  • 39. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS, Women's Health Initiative Mammogram Density Study Investigators.
    J Natl Cancer Inst; 2005 Sep 21; 97(18):1366-76. PubMed ID: 16174858
    [Abstract] [Full Text] [Related]

  • 40. Estrogen with and without progestin: benefits and risks of short-term use.
    LaCroix AZ.
    Am J Med; 2005 Dec 19; 118 Suppl 12B():79-87. PubMed ID: 16414331
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.